SCHEMBL6607250

SCHEMBL6607250

FC(F)(F)COc1ccc2ccccc2n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.51
MAPT P10636 1/20 0.51
KMT2A Q03164 1/20 0.51
HDAC1 Q13547 2/20 0.49
HDAC8 Q9BY41 2/20 0.49
HDAC6 Q9UBN7 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.41
CYSLTR2 Q9NS75 1/20 0.41
CYSLTR1 Q9Y271 1/20 0.41
PDE10A Q9Y233 1/20 0.39
POLB P06746 1/20 0.39
MAPK1 P28482 1/20 0.39
CNR2 P34972 1/20 0.39
NCF1 P14598 1/20 0.38
NOS2 P35228 1/20 0.38
BACE1 P56817 1/20 0.38
CA12 O43570 1/20 0.38
CA9 Q16790 1/20 0.38
CYP1A2 P05177 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24599951 0.83 MEN1 (0.47) MEN1MAPTKMT2AHDAC1HDAC8
SCHEMBL6600702 0.83 MEN1 (0.56) MEN1MAPTKMT2AHDAC1HDAC8
SCHEMBL12933385 0.82 MEN1 (0.51) MEN1MAPTKMT2AHDAC1HDAC8
SCHEMBL28628097 0.79 MEN1 (0.56) MEN1MAPTKMT2AHDAC1HDAC8
SCHEMBL18635352 0.79 L3MBTL1 (0.40) MEN1MAPTKMT2AHDAC1HDAC8
SCHEMBL30224786 0.78 THRB (0.43) MEN1MAPTKMT2AHDAC1HDAC8
SCHEMBL16705084 0.78 CYP1A2 (0.46) KMT2AHDAC1HDAC8HDAC6L3MBTL1
SCHEMBL23993199 0.78 THRB (0.43) MEN1MAPTKMT2AHDAC1HDAC8
SCHEMBL17962772 0.77 THRB (0.46) L3MBTL1BACE1CYP1A2SMN1; SMN2
SCHEMBL9663555 0.76 MAPT (0.61) MEN1MAPTKMT2AHDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1412349-A2 PIPERAZINE OXYQUINOLINE (NAPHTHALINE) PLATELET ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONISTS Schering Aktiengesellschaft (DE) 2004-04-28 EP claimed
WO-2002098856-A2 PIPERAZINE OXYQUINOLINE (NAPHTHALINE) PLATELET ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONISTS SCHERING AKTIENGESELLSCHAFT (DE) 2002-12-12 WO claimed
CN-109400594-A Metal enzyme inhibitor compound 威尔金制药(NC)有限公司 2019-03-01 CN disclosed
CN-103930418-A Metalloenzyme inhibitor compounds VIAMET PHARMACEUTICALS INC 2014-07-16 CN disclosed
CN-103857675-A Metalloenzyme inhibitor compounds VIAMET PHARMACEUTICALS INC 2014-06-11 CN disclosed
US-8697739-B2 Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof NOVARTIS AG (CH) 2014-04-15 US disclosed
EP-1009748-A1 3-ALKYLPYRROLO 3,2-$i(c)]QUINOLINE DERIVATIVES Korea Research Institute of Chemical Technology (KR) 2000-06-21 EP disclosed
WO-2000001696-A1 3-ALKYLPYRROLO[3,2-c]QUINOLINE DERIVATIVES KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2000-01-13 WO disclosed
EP-0968208-A1 QUINOLINE AND QUINAZOLINE COMPOUNDS USEFUL IN THERAPY, PARTICULARLY IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA Pfizer Limited (GB) 2000-01-05 EP disclosed
WO-1998030560-A1 QUINOLINE AND QUINAZOLINE COMPOUNDS USEFUL IN THERAPY, PARTICULARLY IN THE TREATMENT OF BEGNIN PROSTATIC HYPERPLASIA PFIZER LIMITED (GB) 1998-07-16 WO disclosed